Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:496-501 (1 March), doi:10.1136/bmj.39483.457708.80
Andrew J R Parker, specialist registrar1, E Jane Marshall, consultant psychiatrist and senior lecturer2, David M Ball, honorary consultant psychiatrist and senior lecturer3
1 South London and Maudsley NHS Trust, Maudsley Hospital, London SE5 8AZ, 2 Kings College London, Institute of Psychiatry, Addiction Research Unit, London SE5 8AF, 3 Kings College London, Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, London SE5 8AF
Correspondence to: A J R Parker andrew.parker@iop.kcl.ac.uk
| The first 150 words of the full text of this article appear below. |
Alcohol use disorders account for 4% of the global burden of disease and cause 1.8 million deaths (3.2% of total) each year.1 The overall economic cost to society is huge—around £20bn (
26.7bn; $39bn) each year in the United Kingdom—mostly as a result of lost productivity and alcohol related crime.2 Healthcare professionals have a vital role to play in implementing secondary prevention, and in identifying those who need specialist treatment. Well validated screening tools have recently become available, and the effectiveness of early brief interventions and more intensive treatments, together with the cost effectiveness of intensive treatments provide a strong impetus for improving the identification and management of disorders of alcohol misuse.3
|
Read all Rapid Responses